Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 13, 1999

View Archived Issues

Supratek Pharma pipeline update

Antiinflammatory effects of TxA2 antagonist confirmed in patients with asthma

Three new clinical trials of Protein Design Labs' SMART antibodies begin in Q2 1999

Pharming: Q2 1999 highlights

Cambridge Combinatorial, Yamanouchi expand long-term relationship with new deal

Enrollment completed for IntraDose in phase II metastatic liver cancer trial

Dendreon receives FDA premarket approval for stem cell separation device

Dyax acquires Target Quest

Aquila Biopharmaceuticals receives SBIR grant for CD1 tuberculosis vaccine

Company Profile: Karo Bio

Wealth of preclinical data supports anxiolytic potential of 5-HT1A inverse agonist SL-88.0338

Glaxo Wellcome invention describes hypolipidemic activity of novel benzothiazepines

Novel antitumor anthracyclines reported for the first time by Pharmacia & Upjohn

Budipine is a novel and safe antiparkinsonian agent

CPMP adopts positive opinion concerning reformulated Norvir capsules

Emdogain approved by FDA for minimally invasive dental surgery

Buccal insulin effective in controlling postprandial hyperglycemia

Techniclone expands Cotara phase II study in brain tumors

Aviron's EBV vaccine completes phase I trial

Medarex enters antibody development agreement with Eos Biotechnology

CEA-Cide granted orphan drug status for ovarian cancer

Novel MAO-A inhibitors from Sanofi-Synthelabo are claimed for various CNS disorders

Schering-Plough continues research into protein farnesyltransferase inhibitors

New series of erythromycin derivatives reported by Pliva

MMP-3-selective matrix metalloproteinase inhibitors discovered at Pfizer

ADIR researching new treatments for sleep disorders

Bayer will launch new quinolone on September 1

Temodar gets accelerated approval in U.S.; first new drug in 20 years for anaplastic astrocytoma

Sulfated oligosaccharide glycosides with anti-HIV activity described by Japanese team

Pfizer redirects zopolrestat development program

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...